Modern Diagnostic IPO Details
The Modern Diagnostic IPO is a book build issue with a total issue size of ₹37 cr, comprising of fresh issue of 4099200 equity shares. Modern Diagnostic IPO opened for subscription on Dec 31, 2025 and closed on Jan 02, 2026. Modern Diagnostic IPO is set price band at ₹85 to ₹90 per share, with a lot size of 1600 shares. Minimum investment for Retail investors was ₹288,000.00 (at the upper price band) to apply for one lot.
The basis of allotment got finalized on Jan 05, 2026, and listed on both the NSE and BSE on Jan 07, 2026.
MUFG Intime India Private Limited has been appointed as the registrar. Beeline Capital Advisors Pvt Ltd are the Book Running Lead Manager for the issue.
Before investing in the Modern Diagnostic IPO, investors should review the company's financial performance, business objectives, and risk factors mentioned in the offer documents and apply before the subscription window closes.
- Price Band
- ₹ 85 – 90
- Lot Size
- 1600
- Issue Size
- ₹37 Cr
- Minimum Investment
- ₹288000 (3200 Shares)
- Listing Date
- 07 January 2026
Current GMP
₹14 (+15.56%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
About Modern Diagnostic & Research Centre Limited
Modern Diagnostic & Research Centre Limited (MDRC), incorporated in 1985, is a well-established diagnostic services provider in India. The company operates a growing diagnostic chain offering a comprehensive range of pathology and radiology services to individuals, hospitals, and institutional clients.
MDRC is committed to delivering accurate, reliable, and timely diagnostic solutions, supported by advanced technology and experienced medical professionals. Its services include routine and specialized diagnostic testing, home specimen collection, online report access, and customized health packages tailored to the specific requirements of patients and institutional customers.
As of February 28, 2025, MDRC operates 21 centers across 8 Indian states, comprising 17 pathology laboratories and 4 full-fledged diagnostic centers. The company provides a broad spectrum of diagnostic services, including Ultrasound, CT Scan, MRI, X-Ray, ECG, Pulmonary Function Tests (PFT), as well as specialized diagnostic facilities for cardiac and neurological care.
Key Services
Pathology Services
MDRC offers an extensive range of pathology tests, from routine investigations to advanced and specialized diagnostics. These include high-end molecular diagnostics, cytogenetics, and specialized testing panels for genetic disorders, oncology, and other complex medical conditions.
Radiology Services
The company provides advanced imaging services such as MRI, CT scans, ultrasound, and digital X-rays, utilizing state-of-the-art equipment, including a 3-Tesla MRI system and a 128-slice CT scanner, ensuring high-quality imaging and accurate diagnosis.
Home Sample Collection
To enhance patient convenience, MDRC offers home blood sample collection services in multiple cities, catering especially to elderly patients, chronically ill individuals, and those unable to visit diagnostic centers.
Human Resources
As of February 28, 2025, MDRC has a total workforce of 570 employees, including qualified doctors, consultants, technical staff, and support personnel, who collectively contribute to maintaining high standards of diagnostic accuracy and patient care.
Modern Diagnostic IPO Promoters
- Mr. Devendra Singh Yadav
- Mrs. Deepali Yadav
- Mrs. Asha Yadav
- Mr. Jitendra Singh
Promoters Holding
Holding Pre Issue
99.99%
Holding Post Issue
72.85%
Modern Diagnostic IPO Objective
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects.
- Funding capital expenditure for purchase of medical equipment towards establishment of new diagnostic centre and labs
- Funding Working Capital Requirement
- Repayment of certain outstanding borrowings availed by our Company
- General Corporate Expenses
Address / Contact Info
Modern Diagnostic & Research Centre Ltd. Address
Plot No H-64,1st Floor BLK-H,
Bali Nagar City landmark near Khetar Pal Hospital,
Ramesh Nagar, West Delhi
West Delhi, New Delhi, 110015
Phone: 9999474297
Email: compliance@mdrcindia.com
Website: http://www.mdrcindia.com/
IPO Snapshot
Book Running Lead Managers
- Beeline Capital Advisors Pvt Ltd
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Modern Diagnostic IPO is a Book-building IPO with a total issue size of ₹37 crore. The Modern Diagnostic IPO price band is ₹85 to 90 per share. The Modern Diagnostic IPO subscription opens on Wed, Dec 31, 2025, and closes on Fri, Jan 2, 2026. The Modern Diagnostic IPO will be listed on the BSE. MUFG Intime India Private Limited is the registrar for the Modern Diagnostic IPO.
The Modern Diagnostic IPO opens on Wed, Dec 31, 2025 and closes on Fri, Jan 2, 2026
Modern Diagnostic IPO Price Band is ₹85 to 90 per share.
Modern Diagnostic IPO lot size is 1600 shares, Retail investors need a minimum investment of ₹288000 based on the upper price band
The minimum investment for Modern Diagnostic IPO is ₹288000, based on one lot of 1600 shares at the upper price band of ₹90 per share.
Investors can apply for the Modern Diagnostic IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Fri, Jan 2, 2026. The application amount remains blocked until the Modern Diagnostic IPO allotment is finalized.
Modern Diagnostic IPO issue size is ₹37 crores.
Modern Diagnostic IPO allotment date is Wed, Jul 1, 2026.
The registrar for Modern Diagnostic IPO is MUFG Intime India Private Limited. Investors can go to MUFG Intime India Private Limited website to check Modern Diagnostic IPO allotment status, refund processing, and other IPO-related information.
The Modern Diagnostic IPO GMP (Grey Market Premium) is ₹14 as of Wed, Jan 7, 2026. Based on the upper price band of ₹90 per share, the estimated Modern Diagnostic IPO listing price is ₹104, indicating a potential listing gain of approximately 0% over the issue price.